ZA200900899B - Protein matrix vaccines and methods of making and administering such vaccines - Google Patents
Protein matrix vaccines and methods of making and administering such vaccinesInfo
- Publication number
- ZA200900899B ZA200900899B ZA200900899A ZA200900899A ZA200900899B ZA 200900899 B ZA200900899 B ZA 200900899B ZA 200900899 A ZA200900899 A ZA 200900899A ZA 200900899 A ZA200900899 A ZA 200900899A ZA 200900899 B ZA200900899 B ZA 200900899B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccines
- administering
- making
- methods
- protein matrix
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83594406P | 2006-08-07 | 2006-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900899B true ZA200900899B (en) | 2010-07-28 |
Family
ID=41157009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900899A ZA200900899B (en) | 2006-08-07 | 2007-08-07 | Protein matrix vaccines and methods of making and administering such vaccines |
Country Status (2)
Country | Link |
---|---|
CN (2) | CN110064053A (en) |
ZA (1) | ZA200900899B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9724401B2 (en) * | 2011-05-18 | 2017-08-08 | Matrivax, Inc. | Protein matrix vaccine compositions including polycations |
CN110845587B (en) * | 2019-10-15 | 2021-06-29 | 康希诺生物股份公司 | Site-directed mutagenesis carrier protein and application thereof in preparation of vaccine |
CN111450246B (en) * | 2020-05-11 | 2021-04-09 | 中逸安科生物技术股份有限公司 | Trivalent influenza virus subunit vaccine and preparation method thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4761470A (en) * | 1985-12-16 | 1988-08-02 | Merck & Co., Inc. | Immunogenic synthetic peptide capable of eliciting herpes simplex virus neutralizing antibody |
US5153312A (en) * | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
US5961970A (en) * | 1993-10-29 | 1999-10-05 | Pharmos Corporation | Submicron emulsions as vaccine adjuvants |
US5565204A (en) * | 1994-08-24 | 1996-10-15 | American Cyanamid Company | Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
CN1211192A (en) * | 1995-09-18 | 1999-03-17 | 美国陆军医疗材料研究指挥部 | Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines |
CU22983A1 (en) * | 2002-05-08 | 2004-09-09 | Inst Finlay | VACCINE COMPOSITION AGAINST ALLERGIES AND METHOD FOR OBTAINING AND EMPLOYMENT IN THE TREATMENT OF THE SAME |
FR2844514B1 (en) * | 2002-09-16 | 2007-10-19 | Neovacs | STABLE IMMUNOGENIC PRODUCT COMPRISING ANTIGENIC HETEROCOMPLEXES, COMPOSITIONS CONTAINING SAME, AND PREPARATION METHOD |
-
2007
- 2007-08-07 ZA ZA200900899A patent/ZA200900899B/en unknown
- 2007-08-07 CN CN201910333309.5A patent/CN110064053A/en active Pending
- 2007-08-07 CN CN200780037545.8A patent/CN101553246B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN101553246A (en) | 2009-10-07 |
CN110064053A (en) | 2019-07-30 |
CN101553246B (en) | 2019-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2056871A4 (en) | Protein matrix vaccines and methods of making and administering such vaccines | |
IL262205A (en) | Protein formulations and methods of making same | |
IL193198A0 (en) | Long-actine polypeptides and methods of producing and administering same | |
HK1249031A1 (en) | Methods of vaccine administration | |
EP2021455A4 (en) | Cytoblock preparation system and methods of use | |
IL186926A0 (en) | Materials and methods for enhanced degradation of mutant proteins associated with human disease | |
EP2102355A4 (en) | Long acting proteins and peptides and methods of making and using the same | |
IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
IL197501A0 (en) | Modifications of cupredoxin derived peptides and methods of use thereof | |
EP1966246A4 (en) | Methods and compositions for needleless delivery of antibodies | |
IL193700A0 (en) | Medicaments and proteins | |
GB0615635D0 (en) | Immunogenic proteins and uses thereof | |
EP1893233A4 (en) | Therapeutic peptides and vaccines | |
EP2097093A4 (en) | Therapeutic and diagnostic peptides | |
EP2097085A4 (en) | Therapeutic materials and methods | |
ZA200900899B (en) | Protein matrix vaccines and methods of making and administering such vaccines | |
GB0617816D0 (en) | Nucleic acids and methods of protein expression | |
IL186277A0 (en) | Dnt-maleate and methods of preparation thereof | |
IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
ZA200800566B (en) | Therapeutic peptides and vaccines | |
EP1940469A4 (en) | Animal medicament and method of manufature | |
EP1996228A4 (en) | Campylobacter vaccines and methods of use | |
IL192553A0 (en) | Dnt-fumarate and methods of preparation thereof | |
IL190726A0 (en) | Dnt-benzenesulfonate and methods of preparation thereof | |
GB0605761D0 (en) | Anti-inflammatory proteins and improved vaccines |